The starting material for virtually all pharmaceuticals and biologics is a synthetic or chemical. Human plasma-derived therapies are one of the few exceptions. A number of fragile proteins can be ...

Celestial Biologicals Limited (CBL) and GE Healthcare, the US$17 billion healthcare business of General Electric Company, announced have a collaboration to set up India’s first Good Manufacturing ...

The Insight Partners published latest research study on “Plasma Fractionation Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Application, End User, and Geography,” the ...

Grifols' Board of Directors approves a plan for new industrial investments for the Bioscience Division to ensure the company's long-term sustained growth With these new investments, Grifols increases ...

Ottawa, Oct. 30, 2025 (GLOBE NEWSWIRE) -- The global plasma fractionation market size was valued at USD 35.22 billion in 2024 and is predicted to hit around USD 72.86 billion by 2034, rising at a 7.54 ...

Plasma fractionation is a process of separating various components of plasma, which in turn is a component of blood obtained through blood fractionation. BURLINGAME, CA, UNITED STATES, February 10, ...

Newark, Oct. 17, 2023 (GLOBE NEWSWIRE) -- As per the report published by The Brainy Insights, the global Plasma Fractionation market is expected to grow from USD 28.66 Billion in 2022 to USD 49.51 ...